Generative AI will be used to broaden the pool of candidate molecules. Deep learning will be able to identify biomolecules with antibiotic and pharmaceutical potential.
The Infectious Diseases Society of America aimed to develop up-to-date guidance focusing on the treatment of antimicrobial-resistant gram-negative infections.